Venous Thromboembolism Prophylaxis Policy - Royal United ...

More documents

Recommendations

Info

Appendix 2b: Palliative Care Thromboprophylaxis Guideline • For patients undergoing terminal care or on an end-of-life pathway do not use pharmacological or mechanical thromboprophylaxis • For patients undergoing palliative care with potentially reversible acute pathology and is at increased risk of VTE, consider using dalteparin if no contraindications • Review decisions about VTE prophylaxis for patients in palliative care daily, taking into account the views of patients, their families and/or carers and the multidisciplinary team Document name: Venous Thromboembolism Prophylaxis Ref.: 795 Issue date: 30 July 2014 Status: Final Author: Josephine Crowe – Consultant Haematologist Page 22 of 57
PATIENTS IN PALLIATIVE CARE If patient has potentially reversible acute pathology If patient in terminal care or end-of-life care pathway Consider LMWH 1 (dalteparin) if no contraindications, or UFH 2 Do not routinely offer pharmacological or mechanical VTE prophylaxis Review decisions about VTE prophylaxis daily, taking into account potential risks and benefits and views of the patient, family and/or carers and multidisciplinary team 1 See Methods of Prophylaxis 2 For patients with renal failure (EGFR
Page 1 and 2: Venous Thromboembolism Prophylaxis
Page 3 and 4: Appendix 2: General Medicine Thromb
Page 5 and 6: 3 Definition of Terms Used AES DH D
Page 7 and 8: Surgical patients on the combined o
Page 9 and 10: 7.2 Pharmacological prophylaxis and
Page 11 and 12: • Untreated inherited bleeding di
Page 13 and 14: Intermittent pneumatic compression
Page 15 and 16: References 1. Scottish Intercollegi
Page 17 and 18: Appendix 1: Guideline for the Preve
Page 19 and 20: Appendix 2: Guideline General Medic
Page 21: Sequential Compression Devices for
Page 25 and 26: Patients with cancer Patients with
Page 27 and 28: Antenatal VTE risk assessment Previ
Page 29 and 30: Ante-natal or postnatal weight 170
Page 31 and 32: • Varicose veins with phlebitis
Page 33 and 34: Appendix 4a: Vascular, Gastrointest
Page 35 and 36: Patients undergoing general surgery
Page 37 and 38: Patients having day surgery If VTE
Page 39 and 40: • HRT or oestrogen-containing con
Page 41 and 42: Dalteparin Rivaroxaban 10mg po OD T
Page 43 and 44: ELECTIVE HIP REPLACEMENT ELECTIVE K
Page 45 and 46: UKA, TKA, revision TKA • IPC (kne
Page 47 and 48: HIP FRACTURE OTHER ORTHOPAEDIC SURG
Page 49 and 50: Appendix 5b: Trauma and Orthopaedic
Page 51 and 52: Appendix 5c: Trauma and Orthopaedic
Page 53 and 54: Appendix 6: Critical Care Thrombopr
Page 55 and 56: Document Control Information Ratifi
Page 57: Equality Impact: (A) Assessment Scr

Venous Thromboembolism Prophylaxis Policy - Royal United ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?